This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Precision Peptides, Powerful Impact: Protagonist Story of Peptide Innovation from Platform to Patients

Dr. Ashok Bhandari, PhD, Executive Vice President, Chief Discovery Officer, Protagonist Therapeutics

#peptides #peptideinnovation #immunology #metabolicdiseases #peptidechemistry #peptidemanufacturing #maromoleculartherapeutics #moleculardesign #therapeutics #cmcstrategies

Why this is critically important to the peptide / macromolecular therapeutics industry

In this keynote session we hear directly from Protagonist Therapeutics on how they are pushing the boundaries of peptide innovation, advancing a multi-component platform that has already delivered clinical successes with rusfertide and icotrokinra. With a growing pipeline spanning immunology, metabolic diseases, and hematology, you will learn how they are successfully developing their first-in-class oral and subcutaneous peptides, including PN-881 and PN-477. These peptides are poised to transform treatments for obesity, psoriasis and IBD.

This session will showcase how cutting-edge platforms can translate into impactful therapies and commercial success. You will obtain crucial insight into the full development cycle from molecular design to clinical application, understanding how innovative approaches in peptide drug discovery are at the heart of a successful therapeutic pipeline. Learning from a pioneering organization, you’ll be able to learn from their challenges, devise successful strategies, and be part of the discussions shaping the future of peptide therapies.

How will it help your career?

Ideal for those working in peptide companies, peptide chemistry, peptide manufacturing, CMC, and macromolecular therapeutics, this session will provide you with an understanding of how to integrate peptide discovery and platform technology to achieve clinical success. You’ll gain invaluable insights on translating peptide innovation into pipeline strategies and therapeutic development as well as applying insights from successful clinical programs to guide your peptide chemistry, manufacturing and commercialization goals.

Do you want to be at the forefront of peptide innovation? This is your chance to learn just how to do that.

TIDES USA audience in session